Sex-differentiated germline genetic regulation of multiple myeloma risk and survival
Year: 2026
Type: article
Abstract: Multiple myeloma (MM) is a hematologic malignancy in which males have approximately 1.5-fold higher incidence and mortality rates compared to females worldwide, with mortality rates reaching up to 1.7-fold higher in North America. However, the biological mechanisms underlying these observed sex differences remain poorly understood. Here, we investigate sex-differentiated germline genetic effects in MM and their impact on gene expression and survival outcomes. First, we compared sex-stratified MM genome-wide association study (GWAS) summary statistics from the UK Biobank (UKBB) to identify variants with sex-differential genetic effects contributing to MM risk. We then performed a transcriptome-wide association study (TWAS) using S-PrediXcan with GTEx v8 whole blood-derived gene expression prediction models to identify genes that may contribute to sex differential MM risk. Next, we further examined these candidate genes through sex-stratified germline cis-eQTL analyses in CD138⁺ malignant plasma cells from one of the largest MM patient datasets (MMRF CoMMpass study). Finally, we performed sex-stratified survival analyses using Cox proportional hazards models to evaluate the prognostic significance of candidate gene expression in MM. Our results show that sex-differentiated effects extend to genetically regulated tumor gene expression and identified genes, including CD70 , whose expression exhibits sex-dependent associations with MM survival outcomes. Overall, our findings support the presence of sex-differential genetic regulation in MM and that these differences may contribute to sex-dependent tumor gene expression and survival outcomes.
Source: BMC Cancer
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,390
OpenAlex ID: W7237337641
FWCI:
Cites:
Cited by:
Related to:
